Genpact Ltd (G) Stock: What the Analysts are Saying

QCOM

Genpact Ltd (NYSE: G) has a price-to-earnings ratio that is above its average at 12.80x. The stock has a 36-month beta value of 1.17. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 3 as “overweight,” 9 as “hold,” and 2 as “sell.”

The public float for G is 161.62M, and at present, short sellers hold a 3.22% of that float. On November 26, 2024, the average trading volume of G was 1.15M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

G) stock’s latest price update

Genpact Ltd (NYSE: G)’s stock price has soared by 0.97 in relation to previous closing price of 46.19. Nevertheless, the company has seen a gain of 4.36% in its stock price over the last five trading days. prnewswire.com reported 2024-11-21 that Renewed multi-year partnership to support Ferring Pharmaceuticals’ operations in response to rapid business growth NEW YORK, Nov. 21, 2024 /PRNewswire/ — Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that has operating subsidiaries in more than 50 countries and markets its medicines in over 100 countries. The renewed multi-year agreement will continue the transformation of Ferring’s finance, accounting, and procurement operations with advanced technologies, including AI.

G’s Market Performance

Genpact Ltd (G) has experienced a 4.36% rise in stock performance for the past week, with a 21.65% rise in the past month, and a 18.23% rise in the past quarter. The volatility ratio for the week is 1.82%, and the volatility levels for the past 30 days are at 2.10% for G. The simple moving average for the past 20 days is 8.37% for G’s stock, with a 31.04% simple moving average for the past 200 days.

Analysts’ Opinion of G

Many brokerage firms have already submitted their reports for G stocks, with JP Morgan repeating the rating for G by listing it as a “Neutral.” The predicted price for G in the upcoming period, according to JP Morgan is $40 based on the research report published on July 17, 2024 of the current year 2024.

Mizuho, on the other hand, stated in their research note that they expect to see G reach a price target of $40. The rating they have provided for G stocks is “Neutral” according to the report published on January 30th, 2024.

Robert W. Baird gave a rating of “Neutral” to G, setting the target price at $38 in the report published on December 15th of the previous year.

G Trading at 15.07% from the 50-Day Moving Average

After a stumble in the market that brought G to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.79% of loss for the given period.

Volatility was left at 2.10%, however, over the last 30 days, the volatility rate increased by 1.82%, as shares surge +21.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.59% upper at present.

During the last 5 trading sessions, G rose by +4.36%, which changed the moving average for the period of 200-days by +27.68% in comparison to the 20-day moving average, which settled at $43.04. In addition, Genpact Ltd saw 34.37% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at G starting from Kalra Balkrishan, who proposed sale 9,000 shares at the price of $46.40 back on Nov 25 ’24. After this action, Kalra Balkrishan now owns shares of Genpact Ltd, valued at $417,626 using the latest closing price.

White Heather, the Officer of Genpact Ltd, proposed sale 2,541 shares at $46.53 during a trade that took place back on Nov 22 ’24, which means that White Heather is holding shares at $118,233 based on the most recent closing price.

Stock Fundamentals for G

Current profitability levels for the company are sitting at:

  • 0.14 for the present operating margin
  • 0.35 for the gross margin

The net margin for Genpact Ltd stands at 0.14. The total capital return value is set at 0.16. Equity return is now at value 30.11, with 13.36 for asset returns.

Based on Genpact Ltd (G), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33. The debt to equity ratio resting at 0.77. The interest coverage ratio of the stock is 8.6.

Currently, EBITDA for the company is 772.52 million with net debt to EBITDA at 1.05. When we switch over and look at the enterprise to sales, we see a ratio of 1.94. The receivables turnover for the company is 3.78for trailing twelve months and the total asset turnover is 0.88. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.

Conclusion

To sum up, Genpact Ltd (G) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts